|
1
|
Lichtenstein P, Yip BH, Bjork C, Pawitan
Y, Cannon TD, Sullivan PF and Hultman CM: Common genetic
determinants of schizophrenia and bipolar disorder in Swedish
families: A population-based study. Lancet. 373:234–239. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Shorter KR and Miller BH: Epigenetic
mechanisms in schizophrenia. Prog Biophys Mol Biol. 118:1–7. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fouad IA, Sharaf NM, Abdelghany RM and El
Sayed NSED: Neuromodulatory effect of thymoquinone in attenuating
glutamate-mediated neurotoxicity targeting the amyloidogenic and
apoptotic pathways. Front Neurol. 9:2362018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Dore K, Stein IS, Brock JA, Castillo PE,
Zito K and Sjostrom PJ: Unconventional NMDA receptor signaling. J
Neurosci. 37:10800–10807. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ju P and Cui D: The involvement of
N-methyl-d-aspartate receptor (NMDAR) subunit NR1 in the
pathophysiology of schizophrenia. Acta Biochim Biophys Sin
(Shanghai). 48:209–219. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kim TW, Kang HS, Park JK, Lee SJ, Baek SB
and Kim CJ: Voluntary wheel running ameliorates symptoms of
MK-801-induced schizophrenia in mice. Mol Med Rep. 10:2924–2930.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Moghaddam B and Javitt D: From revolution
to evolution: The glutamate hypothesis of schizophrenia and its
implication for treatment. Neuropsychopharmacology. 37:4–15. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Krystal JH, Karper LP, Seibyl JP, Freeman
GK, Delaney R, Bremner JD, Heninger GR, Bowers MB Jr and Charney
DS: Subanesthetic effects of the noncompetitive NMDA antagonist,
ketamine, in humans. Psychotomimetic, perceptual, cognitive, and
neuroendocrine responses. Arch Gen Psychiatry. 51:199–214. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lahti AC, Koffel B, LaPorte D and Tamminga
CA: Subanesthetic doses of ketamine stimulate psychosis in
schizophrenia. Neuropsychopharmacology. 13:9–19. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Javitt DC and Zukin SR: Recent advances in
the phencyclidine model of schizophrenia. Am J Psychiatry.
148:1301–1308. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Duncan GE, Inada K, Koller BH and Moy SS:
Increased sensitivity to kainic acid in a genetic model of reduced
NMDA receptor function. Brain Res. 1307:166–176. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Harrison PJ, Law AJ and Eastwood SL:
Glutamate receptors and transporters in the hippocampus in
schizophrenia. Ann N Y Acad Sci. 1003:94–101. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Emsley JG, Mitchell BD, Kempermann G and
Macklis JD: Adult neurogenesis and repair of the adult CNS with
neural progenitors, precursors, and stem cells. Prog Neurobiol.
75:321–341. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu J, Suzuki T, Seki T, Namba T, Tanimura
A and Arai H: Effects of repeated phencyclidine administration on
adult hippocampal neurogenesis in the rat. Synapse. 60:56–68. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tanimura A, Liu J, Namba T, Seki T,
Matsubara Y, Itoh M, Suzuki T and Arai H: Prenatal phencyclidine
exposure alters hippocampal cell proliferation in offspring rats.
Synapse. 63:729–736. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yamaguchi M, Suzuki T, Seki T, Namba T,
Juan R, Arai H, Hori T and Asada T: Repetitive cocaine
administration decreases neurogenesis in adult rat hippocampus. Ann
N Y Acad Sci. 1025:351–362. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yu J, Qi D, Xing M, Li R, Jiang K, Peng Y
and Cui D: MK-801 induces schizophrenic behaviors through
downregulating Wnt signaling pathways in male mice. Brain Res.
1385:281–292. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bersier MG, Pena C and de Lores Arnaiz
Rodriguez G: The expression of NMDA receptor subunits in cerebral
cortex and hippocampus is differentially increased by
administration of endobain E, a Na+, K+-ATPase inhibitor. Neurochem
Res. 33:66–72. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Baez MV, Cercato MC and Jerusalinsky DA:
NMDA receptor subunits change after synaptic plasticity induction
and learning and memory acquisition. Neural Plast.
2018:50930482018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Evins AE, Fitzgerald SM, Wine L, Rosselli
R and Goff DC: Placebo-controlled trial of glycine added to
clozapine in schizophrenia. Am J Psychiatry. 157:826–828. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Andersson O, Stenqvist A, Attersand A and
von Euler G: Nucleotide sequence, genomic organization, and
chromosomal localization of genes encoding the human NMDA receptor
subunits NR3A and NR3B. Genomics. 78:178–184. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Karlsgodt KH, Robleto K, Trantham-Davidson
H, Jairl C, Cannon TD, Lavin A and Jentsch JD: Reduced dysbindin
expression mediates N-methyl-D-aspartate receptor hypofunction and
impaired working memory performance. Biol Psychiatry. 69:28–34.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Taliaz D, Stall N, Dar DE and Zangen A:
Knockdown of brain-derived neurotrophic factor in specific brain
sites precipitates behaviors associated with depression and reduces
neurogenesis. Mol Psychiatry. 15:80–92. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Glushakov AV, Dennis DM, Morey TE, Sumners
C, Cucchiara RF, Seubert CN and Martynyuk AE: Specific inhibition
of N-methyl-D-aspartate receptor function in rat hippocampal
neurons by L-phenylalanine at concentrations observed during
phenylketonuria. Mol Psychiatry. 7:359–367. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
D'Ascenzo M, Piacentini R, Casalbore P,
Budoni M, Pallini R, Azzena GB and Grassi C: Role of L-type Ca2+
channels in neural stem/progenitor cell differentiation. Eur J
Neurosci. 23:935–944. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ambrosio AF, Silva AP, Malva JO,
Soares-da-Silva P, Carvalho AP and Carvalho CM: Carbamazepine
inhibits L-type Ca2+ channels in cultured rat hippocampal neurons
stimulated with glutamate receptor agonists. Neuropharmacology.
38:1349–1359. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Huang H, Liu L, Li B, Zhao PP, Xu CM, Zhu
YZ, Zhou CH and Wu YQ: Ketamine interferes with the proliferation
and differentiation of neural stem cells in the subventricular zone
of neonatal rats. Cell Physiol Biochem. 35:315–325. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Simoes AP, Silva CG, Marques JM, Pochmann
D, Porciúncula LO, Ferreira S, Oses JP, Beleza RO, Real JI, Köfalvi
A, et al: Glutamate-induced and NMDA receptor-mediated
neurodegeneration entails P2Y1 receptor activation. Cell Death Dis.
9:2972018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Motin VG and Yasnetsov VV: Effect of NMDA,
a specific agonist to NMDA receptor complex, on rat hippocampus.
Bull Exp Biol Med. 159:704–707. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Singh S, Mishra A, Srivastava N and Shukla
S: MK-801 (Dizocilpine) regulates multiple steps of adult
hippocampal neurogenesis and alters psychological symptoms via
Wnt/beta-catenin signaling in parkinsonian rats. ACS Chem Neurosci.
8:592–605. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kysenius K, Brunello CA and Huttunen HJ:
Mitochondria and NMDA receptor-dependent toxicity of berberine
sensitizes neurons to glutamate and rotenone injury. PLoS One.
9:e1071292014. View Article : Google Scholar : PubMed/NCBI
|
